Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to Stakeholders
Specialized Academic Departments and InstitutesIndependent Academic Research Groups

Baylor College of Medicine

United States
5 Trials

Academic medical center in Houston affiliated with multiple Texas Medical Center hospitals. Conducts psilocybin and MDMA clinical trials for veteran PTSD in partnership with the Michael E. DeBakey VA, and houses the ELIPSIS program — a dedicated initiative on the ethical and legal implications of psychedelics in society.

Quick Facts

Type
Other
HQ
United States
Website
Visit

Sponsored Trials

4
RecruitingII

State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma (STARLIGHT)

Start Date
January 30, 2025
Compounds
Psilocybin
RecruitingI

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

Start Date
January 1, 2024
Compounds
Ketamine, Placebo
CompletedII

Optimization of IV Ketamine for Treatment Resistant Depression

Start Date
January 11, 2008
Compounds
Ketamine, Placebo
CompletedIV

Research Study for Major Depressive Disorder: Investigation of Glutamate Medications

Start Date
January 12, 2006
Compounds
Ketamine, Placebo

Collaborated Trials

1
CompletedII

Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)

Start Date
December 1, 2014
Compounds
Ketamine, Placebo

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.